Baidu
map

JAMA:远程缺血预处理对心脏手术患者肾损伤高风险的效果

2015-06-06 MedSci译 MedSci原创

    重要性  目前还没有干预措施来降低心脏手术中的急性肾损伤的风险。    意义  确定远程缺血预处理是否会降低接受心脏手术的患者的急性肾损伤概率和的严重程度。    设计和参与者  在这项多中心试验中,2013年8月和2014年6月期间在德国4家医院共纳入240例处于急性肾损伤高风险的患者,这是由克利夫

重要性  
目前还没有干预措施来降低心脏手术中的急性肾损伤的风险。

意义  
确定远程缺血预处理是否会降低接受心脏手术的患者的急性肾损伤概率和的严重程度。

设计和参与者  
在这项多中心试验中,2013年8月和2014年6月期间在德国4家医院共纳入240例处于急性肾损伤高风险的患者,这是由克利夫兰医学中心评分为6或更高来确定的。研究人员随机将这些患者接受远程缺血预处理或假远程缺血预处理(对照)。所有患者在术后30天完成随访,根据意向治疗原则进行分析。

干预  
接受远程缺血性预处理的患者(在一个上臂麻醉后进行3个循环的5分钟缺血5分钟再灌注),假远程缺血性预处理(对照),都通过血压袖带充气。

主要成果和措施  
主要终点是由肾脏疾病定义急性肾损伤率:即心脏手术后的第一个72小时内改善全球肾脏病预后标准。次要终点包括使用肾脏替代治疗,ICU停留时间,发生心肌梗塞和中风,住院和30天死亡率,改变急性肾损伤生物标志物。

结果  
通过远程缺血预处理显著减少急性肾损伤(120例中的45例[37.5%]),对照组(120例中的63例[52.5%];绝对风险降低15%;95%Cl,2.56%-27.44%;P=0.02)。远程缺血预处理减少患者接受肾脏替代治疗(7 [5.8%] vs 19[15.8%];绝对风险降低10%;95%Cl,2.25%-17.75%;P =0.01),远程缺血性预处理减少重症监护病房停留时间(3天[四分范围,2-5])vs 4天(四分范围,2-7)(P=0.04)。 远程缺血预处理对心肌梗死,中风或者死亡没有显著影响。远程缺血性预处理显著减弱了术后胰岛素样生长因子结合蛋白尿7和金属蛋白酶2组织抑制剂的释放(远程缺血性预处理,0.36 vs 对照,0.97纳克/mL2/1000;差异,0.61;95%Cl,0.27-0.86;P<0.001)。远程缺血性预处理无不良反应报告。

结论  
在进行心脏手术的高危患者中,与无缺血预处理相比,远程缺血性预处理显著减少急性肾损伤和使用肾脏替代治疗率。所观察到的减少急性肾损伤的速率和肾替代值需要进一步研究。

原始出处
Alexander Zarbock, MD1; Christoph Schmidt, MD1; Hugo Van Aken, MD1; Carola Wempe, PhD1; Sven Martens, MD2; Peter K. Zahn, MD3; Britta Wolf, MD3; Ulrich Goebel, MD4; Christian I. Schwer, MD4; Peter Rosenberger, MD5; Helene Haeberle, MD5; Dennis Görlich, PhD6; John A. Kellum, MD7; Melanie Meersch, MD1 ; for the RenalRIPC Investigators,Effect of Remote Ischemic Preconditioning on Kidney Injury Among High-Risk Patients Undergoing Cardiac Surgery,JAMA,2016.6.2


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1861985, encodeId=de2b186198538, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102813, encryptionId=a374102813a1, topicName=高风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Wed Jun 10 19:07:00 CST 2015, time=2015-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35123, encodeId=176a3512324, content=期待有更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 23:14:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27325, encodeId=a5302e325b3, content=注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41521628038, createdName=da1215225, createdTime=Fri Jun 12 16:44:00 CST 2015, time=2015-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26712, encodeId=5c0f26e129c, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Tue Jun 09 19:27:00 CST 2015, time=2015-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1396920, encodeId=47391396920a4, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Mon Jun 08 01:07:00 CST 2015, time=2015-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26209, encodeId=4fab262094b, content=远程缺血性预处理显著减少急性肾损伤和使用肾脏替代治疗率,相对来说这种方法比较简单,在科学上也有研究基础。但是为什么有些结果不一致呢,可能与操作有关系,关键是真的做到缺血预处理, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sun Jun 07 10:26:00 CST 2015, time=2015-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26175, encodeId=91b1261e5d7, content=和之前研究有冲突,需要更大的试验。, beContent=null, objectType=article, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Sat Jun 06 17:14:00 CST 2015, time=2015-06-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1861985, encodeId=de2b186198538, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102813, encryptionId=a374102813a1, topicName=高风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Wed Jun 10 19:07:00 CST 2015, time=2015-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35123, encodeId=176a3512324, content=期待有更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 23:14:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27325, encodeId=a5302e325b3, content=注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41521628038, createdName=da1215225, createdTime=Fri Jun 12 16:44:00 CST 2015, time=2015-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26712, encodeId=5c0f26e129c, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Tue Jun 09 19:27:00 CST 2015, time=2015-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1396920, encodeId=47391396920a4, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Mon Jun 08 01:07:00 CST 2015, time=2015-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26209, encodeId=4fab262094b, content=远程缺血性预处理显著减少急性肾损伤和使用肾脏替代治疗率,相对来说这种方法比较简单,在科学上也有研究基础。但是为什么有些结果不一致呢,可能与操作有关系,关键是真的做到缺血预处理, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sun Jun 07 10:26:00 CST 2015, time=2015-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26175, encodeId=91b1261e5d7, content=和之前研究有冲突,需要更大的试验。, beContent=null, objectType=article, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Sat Jun 06 17:14:00 CST 2015, time=2015-06-06, status=1, ipAttribution=)]
    2015-08-06 hlycom3356

    期待有更多研究

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1861985, encodeId=de2b186198538, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102813, encryptionId=a374102813a1, topicName=高风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Wed Jun 10 19:07:00 CST 2015, time=2015-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35123, encodeId=176a3512324, content=期待有更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 23:14:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27325, encodeId=a5302e325b3, content=注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41521628038, createdName=da1215225, createdTime=Fri Jun 12 16:44:00 CST 2015, time=2015-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26712, encodeId=5c0f26e129c, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Tue Jun 09 19:27:00 CST 2015, time=2015-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1396920, encodeId=47391396920a4, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Mon Jun 08 01:07:00 CST 2015, time=2015-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26209, encodeId=4fab262094b, content=远程缺血性预处理显著减少急性肾损伤和使用肾脏替代治疗率,相对来说这种方法比较简单,在科学上也有研究基础。但是为什么有些结果不一致呢,可能与操作有关系,关键是真的做到缺血预处理, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sun Jun 07 10:26:00 CST 2015, time=2015-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26175, encodeId=91b1261e5d7, content=和之前研究有冲突,需要更大的试验。, beContent=null, objectType=article, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Sat Jun 06 17:14:00 CST 2015, time=2015-06-06, status=1, ipAttribution=)]
    2015-06-12 da1215225

    注意

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1861985, encodeId=de2b186198538, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102813, encryptionId=a374102813a1, topicName=高风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Wed Jun 10 19:07:00 CST 2015, time=2015-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35123, encodeId=176a3512324, content=期待有更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 23:14:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27325, encodeId=a5302e325b3, content=注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41521628038, createdName=da1215225, createdTime=Fri Jun 12 16:44:00 CST 2015, time=2015-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26712, encodeId=5c0f26e129c, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Tue Jun 09 19:27:00 CST 2015, time=2015-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1396920, encodeId=47391396920a4, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Mon Jun 08 01:07:00 CST 2015, time=2015-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26209, encodeId=4fab262094b, content=远程缺血性预处理显著减少急性肾损伤和使用肾脏替代治疗率,相对来说这种方法比较简单,在科学上也有研究基础。但是为什么有些结果不一致呢,可能与操作有关系,关键是真的做到缺血预处理, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sun Jun 07 10:26:00 CST 2015, time=2015-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26175, encodeId=91b1261e5d7, content=和之前研究有冲突,需要更大的试验。, beContent=null, objectType=article, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Sat Jun 06 17:14:00 CST 2015, time=2015-06-06, status=1, ipAttribution=)]
    2015-06-09 huaxipanxing

    看看

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1861985, encodeId=de2b186198538, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102813, encryptionId=a374102813a1, topicName=高风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Wed Jun 10 19:07:00 CST 2015, time=2015-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35123, encodeId=176a3512324, content=期待有更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 23:14:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27325, encodeId=a5302e325b3, content=注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41521628038, createdName=da1215225, createdTime=Fri Jun 12 16:44:00 CST 2015, time=2015-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26712, encodeId=5c0f26e129c, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Tue Jun 09 19:27:00 CST 2015, time=2015-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1396920, encodeId=47391396920a4, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Mon Jun 08 01:07:00 CST 2015, time=2015-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26209, encodeId=4fab262094b, content=远程缺血性预处理显著减少急性肾损伤和使用肾脏替代治疗率,相对来说这种方法比较简单,在科学上也有研究基础。但是为什么有些结果不一致呢,可能与操作有关系,关键是真的做到缺血预处理, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sun Jun 07 10:26:00 CST 2015, time=2015-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26175, encodeId=91b1261e5d7, content=和之前研究有冲突,需要更大的试验。, beContent=null, objectType=article, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Sat Jun 06 17:14:00 CST 2015, time=2015-06-06, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1861985, encodeId=de2b186198538, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102813, encryptionId=a374102813a1, topicName=高风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Wed Jun 10 19:07:00 CST 2015, time=2015-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35123, encodeId=176a3512324, content=期待有更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 23:14:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27325, encodeId=a5302e325b3, content=注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41521628038, createdName=da1215225, createdTime=Fri Jun 12 16:44:00 CST 2015, time=2015-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26712, encodeId=5c0f26e129c, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Tue Jun 09 19:27:00 CST 2015, time=2015-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1396920, encodeId=47391396920a4, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Mon Jun 08 01:07:00 CST 2015, time=2015-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26209, encodeId=4fab262094b, content=远程缺血性预处理显著减少急性肾损伤和使用肾脏替代治疗率,相对来说这种方法比较简单,在科学上也有研究基础。但是为什么有些结果不一致呢,可能与操作有关系,关键是真的做到缺血预处理, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sun Jun 07 10:26:00 CST 2015, time=2015-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26175, encodeId=91b1261e5d7, content=和之前研究有冲突,需要更大的试验。, beContent=null, objectType=article, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Sat Jun 06 17:14:00 CST 2015, time=2015-06-06, status=1, ipAttribution=)]
    2015-06-07 medcardio

    远程缺血性预处理显著减少急性肾损伤和使用肾脏替代治疗率,相对来说这种方法比较简单,在科学上也有研究基础。但是为什么有些结果不一致呢,可能与操作有关系,关键是真的做到缺血预处理

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1861985, encodeId=de2b186198538, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102813, encryptionId=a374102813a1, topicName=高风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Wed Jun 10 19:07:00 CST 2015, time=2015-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35123, encodeId=176a3512324, content=期待有更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 23:14:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27325, encodeId=a5302e325b3, content=注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41521628038, createdName=da1215225, createdTime=Fri Jun 12 16:44:00 CST 2015, time=2015-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26712, encodeId=5c0f26e129c, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Tue Jun 09 19:27:00 CST 2015, time=2015-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1396920, encodeId=47391396920a4, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Mon Jun 08 01:07:00 CST 2015, time=2015-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26209, encodeId=4fab262094b, content=远程缺血性预处理显著减少急性肾损伤和使用肾脏替代治疗率,相对来说这种方法比较简单,在科学上也有研究基础。但是为什么有些结果不一致呢,可能与操作有关系,关键是真的做到缺血预处理, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sun Jun 07 10:26:00 CST 2015, time=2015-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26175, encodeId=91b1261e5d7, content=和之前研究有冲突,需要更大的试验。, beContent=null, objectType=article, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Sat Jun 06 17:14:00 CST 2015, time=2015-06-06, status=1, ipAttribution=)]
    2015-06-06 owlhealth

    和之前研究有冲突,需要更大的试验。

    0

相关资讯

Stroke:治疗急性局灶性缺血性脑卒中的新方法

 一项最新研究表明,在早期入院且年龄大于70岁或患有轻度中风的患者中,一种可增加脑血流量的新型导管治疗(NeuroFlo)法对其全因死亡率有效,但是否适合临床普及,尚有待进一步的确认。该项研究成果已在线发表于《卒中》期刊网站。 目前,接受治疗的急性局部缺血性脑卒中患者不足5%,而且其对额外可选择的疗法尚有需求。一种可增加脑血流量的新型导管治疗(NeuroFlo)接受了长达14小时的检

JACC Cardiovasc Interv:解剖学负荷预测结果优于缺血负荷(COURAGE亚组研究)

根据最近发表于JACC的一项COURAGE亚组研究显示,解剖学负荷对于采用最佳药物治疗(有或无血运重建治疗)的稳定型冠心病患者是一个良好的预测结果,而非缺血性负荷。 首席研究员G.B.约翰•曼奇尼博士指出,在这些患者中使用各种药物治疗和血管形成术,结果显示缺血基线水平并不能预测的风险,而低射血分数或冠状动脉疾病的量在整个试验中该作用未间断。 但是除药物治疗外,无论危险分层措施单独或组合使用均有

张运:冠心病发病机制的“太阳系”新概念--关注缺血而非狭窄

一、“金标准”的由来目前临床上,无论诊断或治疗,均严格遵循“金标准”——冠状动脉造影的结果。冠状动脉造影显示患者血管直径狭窄≥50%,即诊断为冠心病。即使包括心电图、超声心动图和核磁等在内的其他诊断技术检测结果呈阳性,只要造影显示狭窄<50%,就认定其他结果为假阳性;反过来,其他检测结果呈阴性,只要造影显示为阳性,就认定其他结果为假阴性。而治疗标准为:≥70%的狭窄实施介入治疗,<70%则不进

NEJM:手指缺血性坏死一例

患者,女,69岁,双手手指呈缺血性坏死症状,症状持续有2月(图A和图B)。一年前,患者曾患过肖格伦综合征,并且发展为雷诺综合征,具疼痛感。 A B 硝苯地平和局部硝酸甘油治疗后不改善症状。患者不抽烟,有巨球蛋白血症家族病史。血液检测提示冷球蛋白阳性,血清蛋白电泳结合免疫固定提示在分子量为345mg/dL的地方有一单克隆IgM抗体峰伴随kappa轻链限制性。乙肝

Nat Commun:缺血坏死心肌交感神经支配或能重建

最近Case Western Reserve University的科学家们意外发现用于恢复脊髓功能的化合物可能有另外一个神奇的作用-阻止心肌缺血坏死后致命性心律失常的发生。这种特殊的物质能进入心肌瘢痕促进心脏神经的再生。这个研究发表在最新一期的Nature Communications杂志上。 这种化合物名为西格玛内肽(intracellular sigma peptide, ISP),一

新型溶栓药物desmoteplase出现转机 能改善缺血性卒中的预后

今年6月,灵北(Lundbeck)新一代溶栓药物去氨普酶(desmoteplase)首个III期研究(DIAS-3)失败,为该药临床项目的推进蒙上了阴影。此前,业界曾对该药寄予厚望,FDA也已授予该药快车道地位。近日,desmoteplase临床项目似乎迎来转机,采用新的分析方法发现,desmoteplase与较好的功能预后相关。新分析数据同时表明,检测早期缺血性损伤时,与电脑断层扫描(CT)相比

Baidu
map
Baidu
map
Baidu
map